like gener franchis mani undifferenti acquisit
made cover constant downward deterior base busi certain
point new product cycl need materi case materi
enough way believ quarter confirm thesi would avoid even
valuat
second quarter result consensu led downward revis
guidanc revenu reach y/i roughli
street led earn y/i consensu
given lack advair restasi approv revenu guidanc lower
previous given origin
spread low-to-high end previous obvious major disappoint
rang need lower clearli core busi rapidli deterior
confirm thesi given revenu reduct earn expect
correspondingli lower lower estim
correspondingli lower price target per share
despit lower revenu expect manag maintain cash flow
guidanc would stress level cash flow similar
record despit acquisit last
year addit ebitda via purchas
use observ via roughli acquir current market
product unsur total sale product acquir
underscor strategi continu take balanc sheet bolster
 specif net cash provid oper activ
help lower capital-expenditure make
adjust free cash flow guidanc forecast declin y/i
estim fairli indic true underli trend bad
larger pictur continu view roughli flat cash gener
last year guid year good marker health lack thereof
busi analysi see share repurchas line
alter stress rel unchang cash gener observ
last year project manag y/i
despit spent acquisit ad roughli ebitda specif
februari acquir abbott establish product june
acquir august acquir meda
believ long-term investor cash gener trend troubl
caus paus analyz health underli busi addit
would note spend roughli appear
launch new drug model upsid fact like gener
manufactur believ lack cash gener new product introduct
despit headi spend caus question entir busi model
pleas see page report import disclosur
